Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-acceleratedįiler, a smaller reporting company or an emerging growth company.
CANDELA MEDICAL REGISTRATION
☐Īmendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. Registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act
The Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
CANDELA MEDICAL ZIP
(Name, address, including zip code, and telephone number, including area code, of registrants agent for service)Īpproximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement is declared effective. (Address, including zip code, and telephone number, including area code, of registrants principal executive offices) (Exact name of registrant as specified in its charter) Seelaus & Co.As filed with the Securities and Exchange Commission on October 19, 2021 27, 2021, hours ahead of when the IPO was scheduled for pricing.)ĮLECTROMEDICAL (LASER) & ELECTROTHERAPEUTIC APPARATUSĢ51 Locke Drive, Marlborough, Massachusetts 01752, Uīaird/ Canaccord Genuity/ Stifel/ Oppenheimer & Co./ Stephens, Inc./ ING/ R. Previously: Candela Medical postponed its IPO “due to market conditions” on Oct.
(Candela Medical withdrew its IPO plans in an SEC document dated Sept. Through our category-leading products, innovative treatments, robust clinical evidence, extensive post-sale support, and other value drivers, we facilitate practice growth and a quick return on their investment. We seek to be the partner of choice for aesthetic practitioners by bringing the best technology solutions to their practices. Trust.” guides our commitment to patients who can expect efficacious and clinically proven results when receiving a procedure involving a Candela device. We provide energy-based solutions for primarily elective cash-pay procedures that utilize our leading technologies in laser, pulsed light, RF and microneedling. Our brands and products have been recognized for their innovation and as leaders in the high growth medical aesthetics space for almost 40 years. We are a leading provider of advanced medical device solutions for a broad range of aesthetic applications.
27, 2021, hours ahead of when the IPO was scheduled for pricing.) (Note: Candela Medical withdrew its IPO plans in an SEC document dated Sept.
0 kommentar(er)
